Objective: To compare post-TKA (total knee arthroplasty) analgesic effect of periarticular injection of different analgesics during surgery. Study Design: Experimental study. Place and Duration of Study: Tianjin People's Hospital, from December 2016 to July 2018. Methodology: Patients undergoing unilateral TKA were randomly divided into Group A and Group B, with 67 patients in each group. In Group A, compound analgesics of ropivacaine, ketorolac, adrenaline, morphine and normal saline were injected periarticularly during surgery. While in Group B, compound analgesics of bupivacaine, methylprednisolone, adrenalin, morphine and normal saline were injected periarticularly during surgery. Visual analogue scale (VAS), range of motion (ROM) of knee joint, and rehabilitation of knee joint of both groups were compared. Results: VAS scores of Group A at 6-hour, 24-hour, 48-hour and 72-hour after surgery was lower than those of Group B (p=0.046, p<0.001, p<0.001 and p<0.001, respectively). ROM of knee joint of Group A on the 3 rd , 7 th , 10 th and 14 th day after surgery was superior to that of Group B (all p<0.001). On the 14th day after surgery, excellent and good rate of rehabilitation of knee joint of Group A was higher than that of Group B (p=0.032). Conclusion: Compared with periarticular injection of compound analgesics of bupivacaine, methylprednisolone, adrenaline, morphine and normal saline during surgery, periarticular injection of compound analgesics of ropivacaine, ketorolac, adrenaline, morphine and normal saline during surgery can alleviate post-TKA pain more effectively, improve early ROM of joint knee after surgery, increase rehabilitation effect of knee joint.
INTRODUCTION
Total knee arthroplasty (TKA) refers to the use of a prosthesis made of artificial material to replace a knee joint, to improve the pain, limited ROM and joint deformity as a result of knee osteoarthritis, rheumatoid arthritis and knee trauma, etc. and reconstruct a joint with almost normal functions, and restore and improve the mobility of joint, 1,2 thereby improving the patients' quality of life. Pain is the most common early complication following a surgery. The acute pain within 24h after surgery can postpone the early rehabilitation training of patients after TKA; and directly affect their functional recovery and surgical effect. 3 Controlling postoperative pain properly plays a significant role in the post-TKA rehabilitation of patients' knee functions. Although the use of a patient-controlled analgesia (PCA) pump can control postoperative pain to a certain extent, using a large dose of morphine can easily lead to urinary retention, respiratory depression and other side effects. 4 Other analgesic methods, such as continuous epidural block, continuous lumbar plexus block, and continuous femoral nerve block can also control pain and reduce the use of analgesics, but are prone to muscle weakness, neurologic impairment and other complications. 5, 6 The periarticular injection of mixed analgesics is a novel method to relieve pain after surgery. Research has shown the intraarticular injection of analgesics during a knee joint surgery can alleviate pain after the surgery effectively. 7 However, the efficacy of the intraarticular injection of analgesics during TKA remains unclear. Ropivacaine, ketorolac, adrenaline and bupivacaine, etc. are common drugs for local anesthesia. Adolph et al. reported that injecting compound analgesics, such as bupivacaine, morphine and adrenaline into the soft tissues around joints during surgery, can reduce the postoperative VAS score, the demand for morphine and postoperative blood loss. 8 and normal saline during surgery and the periarticular injection of compound analgesics of bupivacaine, methylprednisolone, adrenaline, morphine and normal saline during surgery. 9 
METHODOLOGY
This study was conducted at Tianjin People's Hospital, from December 2016 to July 2018. It was approved by the Hospital Ethics and Research Committee. A total of 134 patients receiving unilateral TKA at the Hospital from September 2016 to May 2018 were selected. The inclusion criteria were patients who were diagnosed as knee osteoarthritis or rheumatoid arthritis and intended to receive a unilateral TKA; patients with preoperative chronic pain in the unilateral knee joint, accompanied by functional disorder, who did not respond to conservative treatment; whose preoperative ASA grading (the preoperative grading criteria of the American Society of Anesthesiologists) was I-II and who signed informed consent before surgery. The exclusion criteria were patients with bilateral knee joints involvements; a history of drug dependence or allergy to narcotics; a history of stroke or neuropsychiatric disorder; coagulation dysfunction; obvious fixed deformity; communication disorders; and who were allergic to the medicines injected in this study. All the patients were divided into Group A and Group B randomly, with 67 patients in each group, using the random number table.
Both groups received unilateral TKA (all of the surgeries were performed by the same group of surgeons and anesthetists). After the installation of prosthetic limbs, different compound analgesics were injected into the quadriceps femoris device, tenaculum, medial collateral ligament, fat and subcutaneous tissues and infiltrated. Among them, Group A was given 400 mg ropivacaine, 30 mg ketorolac, 0.3 mg adrenaline, 5 mg morphine and normal saline (with a total volume of 40 mL). Group B was administered 200 mg bupivacaine, 40 mg methylprednisolone, 0.3 mg adrenaline, 5 mg morphine and normal saline (with a total volume of 40 mL). On the other hand, patients in two groups were injected with 75 mg pethidine intramuscularly 6h after surgery. Another injection of 75 mg pethidine would be given at an interval of 6-10h, depending on the degree of pain. The next day 400 mg/d COX-2 inhibitor (Celecoxib) was administered orally.
Patients in both groups adopted the same rehabilitation training method, that is, to start active dorsiflexion of ankle joint after surgery, and initiate CPM (continuous passive motion) training on the 2 nd day after surgery, and they were allowed to use a pair of crutches to bear part of the load.
The pain scores of patients on admission and 6-hour, 24-hour, 48-hour and 72-hour after surgery (in a resting state) were observed and recorded using a visual analogue scale (VAS). The ROM of knee joint of patients on the 3 rd , 7 th , 10 th and 14th day after surgery was monitored, to evaluate the recovery of knee joint. On the 14th day after surgery, the HSS scores of the patients were measured, in order to assess the recovery of knee function. The HSS score was composed of 7 categories, with a total score of 100 points. Among them, 6 categories were addition categories, that is, 30 points for pain, 22 points for function, 18 points for range of motion, 10 points for muscle strength, flexion deformity and instability each. One category was deduction category, which involved crutch use, varus and valgus deformity and extensor lag. Based on these scores, the clinical effects were rated as excellent (>85), good (70-84), medium (60-69) or poor (<59). The excellent and good rate = (excellent+ good cases)/total cases×100%. Meanwhile, both groups were compared in terms of the occurrence of postoperative complications.
Data was analysed in SPSS version 21. Mean value ±SD was calculated for numerical variables like VAS pain score and ROM, examined by independent sample t-test. Frequencies and percentages were calculated for categorical variables like gender, knee rehabilitation. Chi-square test was applied to compare the categorical variables in two groups. Results were considered significant at p <0.05.
RESULTS
Of the 134 patients, 34 (25.37%) patients were males and 100 (74.63%) patients were females, aged 57-73 (65.41 ±3.25) years. TKA operation was performed on the left knee in 64 (47.76%) cases and on the right knee in 70 (52.24%) cases. The body mass index was 21-27 (23.86 ±1.72) kg/m 2 . There were 103 (76.87%) cases of osteoarthritis of the knee and 31 (23.13%) cases of rheumatoid arthritis. Preoperative ASA level: 49 (36.57%) cases were in level I, 85 (63.43%) cases were in level II.
There was no significant difference between Group A and Group B in terms of the VAS score on admission (p=0.930). The VAS scores of Group A 6-hour, 24-hour, 48-hour and 72-hour after surgery (in a resting state) was lower than those of Group B (p=0.046, p<0.001, p<0.001 and p <0.001, respectively, Table I ). The ROM of knee joint of Group A on the 3 rd , 7 th , 10 th and 14 th day after surgery was superior to that of Group B (all p<0.001, Table II ).
On the 14th day after surgery, excellent and good rate of the rehabilitation of knee joint of Group A was 91.04% (61 cases), which was higher than that of Group B at 77.61% (52 cases) (p=0.032) (Table III) .
No wound complication or toxicity in the heart or central nervous system was observed in either group due to the injection of compound analgesics.
DISCUSSION
Some studies found that the intraarticular injection of local anesthetic after TKA could reduce postoperative pain. 10 Tsukada et al. also confirmed that compared with epidural analgesia, the periarticular injection of local anesthetic had a better postoperative analgesic effect, earlier recovery of the flexion angle of knee, and lower incidence of nausea. 11 On the other hand, some studies pointed out that injecting local anesthetics into the articular cavity after TKA did not diminish the use of postoperative analgesics. 12 Ritter et al. argued that patients undergoing TKA and receiving intraarticular injection, who were divided into four groups, i.e., placebo, morphine, bupivacaine and morphine+ bupivacaine, had no difference in the length of stay, the pain score, and the use of analgesics and nonsteroidal anti-inflammatory drugs (NSAIDS) 24 hours after surgery. 13 At present, the main ingredient of most clinical drugs injected into the soft tissues around the joint is local anesthetics, combined with morphine, hormone and NSAIDS. In this study, both groups use adrenaline and morphine. Adrenaline slows down the absorption of the analgesics by contracting blood vessels, which prolongs the efficacy of drugs while reducing its toxicity, and also diminishes postoperative and intraoperative bleeding. 14, 15 There are abundant opioid receptors in the surrounding inflammatory tissue, the receptors appear shortly after trauma and bind to morphine effectively to reduce pain. 16 A randomised double-blind study revealed addition of morphine and ketolorac to ropivacaine intraarticularly enhanced analgesic efficacy of local anesthesia, reduced postdischarge analgesic consumption. 17 The present study confirms that compared with the intraoperative injection of compound analgesics in Group B, the intraoperative injection of compound analgesics in Group A can lower the VAS score of patients in a resting state 24 hours after surgery more effectively; and improve the early ROM after surgery. It is suggested that the periarticular injection of compound analgesics of ropivacaine, ketorolac, adrenaline, morphine and normal saline during surgery can better control post-TKA pain and contribute to the rehabilitation of the knee functions of patients. This conclusion is basically consistent with those of other studies. 18 The possible reasons include: first of all, ropivacaine and bupivacaine are long-acting local anesthetics with similar pharmacokinetics, but ropivacaine has lower toxicity and lasts longer than bupivacaine. So the duration of analgesia in Group A is longer, which is conducive to the functional training of patients after surgery. Secondly, Group A takes ketorolac as NSAID. NSAIDS inhibits the activity of COX-2 through a variety of pathways, including the synthesis of prostaglandin, inhibits lipoxidase pathway, interferes with the signal transduction mediated by G-protein and binds with opioid receptors in order to achieve the effect of analgesia. 19 Thirdly, ketorolac synergizes with morphine, enhances the analgesic effect and achieves the effect of analgesia. 20 One study reported that COX-2 inhibitor can increase the risk of heart diseases. 21 Although both groups adopt COX-2 inhibitor (Celecoxib) after surgery, no wound complication or toxicity in the heart or central nervous system is observed in either group due to the injection of compound analgesics. This may be related to the small sample size included in the present study. In view of this, further studies are needed to confirm the exact effect of COX-2 inhibitor on the risk of cardiovascular diseases. The authors intend to increase the sample size and optimise the evaluation indicators, to further support the clinical effect of the periarticular injection of compound analgesics of ropivacaine, ketorolac, adrenaline, morphine and normal saline during TKA. 
